Market Place
Sourcing Support
Hepion Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment
13 Nov 2023 //
GLOBENEWSWIRE
Hepion Pharmaceuticals Schedules Conference Call
10 Nov 2023 //
GLOBENEWSWIRE
Hepion Pharmaceuticals™ Rencofilstat Demonstrates Anti-Cancer Activity
25 Oct 2023 //
GLOBENEWSWIRE
New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals™ Rencofilstat
21 Sep 2023 //
GLOBENEWSWIRE
Rencofilstat Produces Positive Outcomes in Translational Study
14 Sep 2023 //
GLOBENEWSWIRE
Hepion Schedules Conference to Review Results from Trial of Rencofilstat
19 May 2023 //
GLOBENEWSWIRE
EPO Decision to Grant EU Patent for Rencofilstat Strengthens Hepion Patent Portfolio
02 Mar 2023 //
GLOBENEWSWIRE
Hepion to Deliver Updates on Phase 2 NASH Clinical Program with Rencofilstat
02 Mar 2023 //
GLOBENEWSWIRE
Presentation of Study Highlighting Activity of Rencofilstat with Proteosome
10 Jan 2023 //
GLOBENEWSWIRE
Hepion Pharma to Present Ph2a Rencofilstat Multiomics Data at NASH-TAG 2023
05 Jan 2023 //
GLOBENEWSWIRE
Hepion Pharma Bags FDA ODD stautus for Rencofilstat in Hepatocellular Carcinoma
20 Jun 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.